Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead

» Why New Wegovy Deals Won’t Restore Novo Nordisk’s Obesity Lead

By:
On:
In: Business
With: 0 Comments




The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only getting wider.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *